Sponsor Pipeline

Nanogen Pharmaceutical Biotechnology Joint Stock Company Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06919861 Pharmacokinetics, Pharmacodynamics, and Safety of NANOKINE Compared With Eprex 4000 U in… Pharmacokinetics and Pharmacodynamics in Healthy Volunteers Not Yet Recruiting
Get alerts when Nanogen Pharmaceutical Biotechnology Joint Stock Company's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free